Download video

"Inflammasomes from bench to bedside" by Dr. Eicke Latz

3K views

GLOBAL IMMUNOTALKS

3 years ago

"Inflammasomes from bench to bedside" by Dr. Eicke Latz

"Inflammasomes from bench to bedside" by Dr. Eicke Latz

\\
56:28
\\"Inflammasomes from bench to bedside\\" by Dr. Eicke Latz
by GLOBAL IMMUNOTALKS
4\/26\/22 Inflammasomes and Related Diseases
1:16:04
4\/26\/22 Inflammasomes and Related Diseases
by UW AI Teaching Series
\\
55:02
\\"Regulation of inflammasome activation and formation\\" by Dr. Clare Bryant
by GLOBAL IMMUNOTALKS
How I Treat Autoinflammatory Disorders: NLRP3: From Autoinflammation to Metaflammation
1:34:08
How I Treat Autoinflammatory Disorders: NLRP3: From Autoinflammation to Metaflammation
by Appraise To Raise Program
NAIP5-NLRC4 Inflammasome
0:32
NAIP5-NLRC4 Inflammasome
by Howard Hughes Medical Institute (HHMI)
From Bench to Bytes: Prediction of Bacterial Type 9 Secretion System and Associated Functionalities
21:54
From Bench to Bytes: Prediction of Bacterial Type 9 Secretion System and Associated Functionalities
by matsciencechannel
Immunometabolism in inflammation and coagulation by Dr. Luke O’Neill
56:52
Immunometabolism in inflammation and coagulation by Dr. Luke O’Neill
by GLOBAL IMMUNOTALKS
Food \& Environmental Allergy Testing: Zonulin \& Histamine - Rupa Health
1:11:15
Food \& Environmental Allergy Testing: Zonulin \& Histamine - Rupa Health
by Rupa Health
Man S M (2019): The inflammasome: an anti-microbial machinery against bacterial infection
54:02
Man S M (2019): The inflammasome: an anti-microbial machinery against bacterial infection
by WEHI Seminars
InflammaZoom Episode 2 | Hudson Institute of Medical Research
1:25:23
InflammaZoom Episode 2 | Hudson Institute of Medical Research
by Hudson Institute of Medical Research
SMILE protein shows therapeutic potential in rheumatoid arthritis by inhibiting B cell activation
1:38
SMILE protein shows therapeutic potential in rheumatoid arthritis by inhibiting B cell activation
by AJE Video Bytes
Update on Phase I\/II study of azacitidine, venetoclax and gilteritinib in patients with FLT3+ AML
2:11
Update on Phase I\/II study of azacitidine, venetoclax and gilteritinib in patients with FLT3+ AML
by VJHemOnc – Video Journal of Hematology \& HemOnc
Oral combination of ASTX727 (decitabine\/cedazuridine) plus Ven for older\/unfit patients with AML
2:23
Oral combination of ASTX727 (decitabine\/cedazuridine) plus Ven for older\/unfit patients with AML
by VJHemOnc – Video Journal of Hematology \& HemOnc
Innate Immunity and Inflammasome activation in response to SARS-CoV-2 by Dr. Dario Zamboni
55:59
Innate Immunity and Inflammasome activation in response to SARS-CoV-2 by Dr. Dario Zamboni
by GLOBAL IMMUNOTALKS
Moecking J (2019): Investigating the molecular basis of human NLRP1 inflammasome activation
51:54
Moecking J (2019): Investigating the molecular basis of human NLRP1 inflammasome activation
by WEHI Seminars
Dipeptide repeat proteins and the NLRP3 inflammasome in FTD
0:57
Dipeptide repeat proteins and the NLRP3 inflammasome in FTD
by VJDementia